Peter Marks’ ouster comes at a time when the sector is already suffering through a years-long public markets slump.
Marks offered his resignation while citing Kennedy’s “misinformation and lies” and an “unprecedented assault on scientific ...
The pharma industry, Wall Street and former government officials on Monday decried the forced resignation of FDA vaccine ...
The sudden resignation of Peter Marks, M.D., Ph.D., from the FDA branch that regulates biological products for humans ...
Dr. Peter Marks announced his resignation from the U.S. Food and Drug Administration (FDA) as Director of CEBR (Center for ...
As the FDA’s top biologics official, Peter Marks oversaw regulation of cell and gene therapies. The departure of Marks and ...
Dr. Peter Marks, director of the Center for Biologics Evaluation and Research at the FDA, resigns after being pressured by ...
Vaccine makers were hit particularly hard yesterday, as Marks’ resignation letter alluded to disagreements with HHS Secretary ...
Dr. Peter Marks, the top vaccine official at the Food and Drug Administration, wrote in a letter that he was resigning from ...
Biotech stocks took a hit after the sudden resignation of Dr. Peter Marks, head of the FDA’s Center for Biologics Evaluation ...
As the FDA wavers from cuts, changes and departures under the second Trump administration, another vital figure of the agency ...
Dr. Peter Marks announced his resignation from the U.S. Food and Drug Administration (FDA) as Director of CEBR (Center for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results